Our data demonstrated that CDKN2B-AS1 could promote CRC cell proliferation and migration and facilitate CRC tumor growth through the miR-378b/cytoplasmic activation/proliferation-associated protein 2 (CAPRIN2) axis. Here, CDKN2B is linked to neoplasm.